Phreesia Recognition Highlights Commitment to Employee Well-Being, Remote Culture, and Professional Growth Phreesia, a recognized leader in patient intake, outreach, and activation solutions, has earned a place on Becker’s Healthcare’s…
Pediatrix Strengthens Clinical Leadership with Appointment of Two Distinguished Physician Experts Pediatrix® Medical Group,a leading provider of physician services focused on women, babies and children, has announced the addition of…
InterSystems Appoints Dr. Tim Ferris as Vice President of Healthcare Practices InterSystems, a global provider of advanced data technology solutions that supports the management of more than one billion healthcare…
Epiphany Dermatology Expands into New Jersey Through Strategic Partnership with Affiliated Dermatologists & Dermatologic Surgeons Epiphany Dermatology, a prominent and rapidly growing dermatology platform dedicated to enhancing access to high-quality…
UL Research Institutes’ Chemical Insights to Present Safety Science Research at Society of Toxicology 65th Annual Meeting and ToxExpo UL Research Institutes’ Chemical Insights is set to play a significant…
Bristol Myers Squibb gains U.S. Food and Drug Administration and European Medicines Agency approvals, expanding Opdivo use in Hodgkin lymphoma Bristol Myers Squibb has announced significant regulatory milestones that mark…
Incyte Showcases HS Data at AAD 2026 Incyte has announced that it will present a comprehensive set of new clinical data from its Inflammation and Autoimmunity (IAI) portfolio at the…
Fulgent Genetics finalizes $56.9 million deal to expand pathology and dermatopathology capabilities with Bako Diagnostics and StrataDx Fulgent Genetics, Inc., a technology-driven company known for its strong laboratory services platform…
Aarvik Therapeutics Unveils Novel ADCs at AACR 2026 Aarvik Therapeutics, a biotechnology company focused on advancing antibody-drug conjugate (ADC) technologies, has announced its participation in the AACR Annual Meeting 2026,…
WuXi Biologics Earns Multiple Asia-Pacific Biopharma Excellence Awards for Advancements in Bioprocessing, Manufacturing Quality, and Digital Innovation WuXi Biologics a leading global Contract Research, Development and Manufacturing Organization (CRDMO), announced…
Planet DDS 2026 Dental Outlook Shows More New Patients, Fewer No-Shows Across the Industry Planet DDS, a leading provider of cloud-based, enterprise-grade dental software solutions, announced the release of its 2026…
Parabilis Medicines’ Zolucatetide, the First and Only Direct Inhibitor of the Elusive β-catenin:TCF Interaction, Receives FDA Orphan Drug Designation for the Treatment of Desmoid Tumors Parabilis Medicines, a clinical-stage biopharmaceutical…